Source:http://linkedlifedata.com/resource/pubmed/id/16644716
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0017337,
umls-concept:C0021655,
umls-concept:C0028754,
umls-concept:C0043157,
umls-concept:C0085295,
umls-concept:C0086860,
umls-concept:C0205419,
umls-concept:C0332281,
umls-concept:C0337810,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-4-28
|
pubmed:abstractText |
Interleukin (IL)-10 is a major anti-inflammatory cytokine that has been associated with obesity and type 2 diabetes. The three polymorphisms -1082G/A, -819C/T, and -592C/A in the IL10 promoter were reported to influence IL10 transcription. We investigated whether these polymorphisms were associated with type 2 diabetes and related traits in a cohort of Italian Caucasians comprising 551 type 2 diabetic and 1,131 control subjects. The -819C/T and -592C/A polymorphisms were in perfect linkage disequilibrium (r(2) = 1.0). The -1082G/A polymorphism was not associated with type 2 diabetes or related traits. Although the -592C/A polymorphism was not associated with type 2 diabetes, nondiabetic homozygous carriers of the A allele showed increased BMI and insulin resistance and lower plasma IL-10 levels compared with the other genotypes. In the nondiabetic group, the ATA haplotype was associated with an increased risk for obesity (odds ratio 1.28 [95% CI 1.02-1.60]; P = 0.02). The ATA/ATA composite genotype was associated with an increased risk for obesity (1.96 [1.16-3.31]; P = 0.01) and insulin resistance (1.99 [1.12-3.53]; P = 0.01). This study suggests that polymorphisms and haplotypes of the IL10 promoter may be associated with obesity and insulin resistance in a large sample of Italian Caucasians.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0012-1797
|
pubmed:author |
pubmed-author:AndreozziFrancescoF,
pubmed-author:CardelliniMarinaM,
pubmed-author:HribalMarta LetiziaML,
pubmed-author:LarattaEmanuelaE,
pubmed-author:LauroRenatoR,
pubmed-author:MariniMaria AdelaideMA,
pubmed-author:PerticoneFrancescoF,
pubmed-author:ScarpelliDanielaD,
pubmed-author:SestiGiorgioG,
pubmed-author:TassiVittorioV
|
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1529-33
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16644716-Adult,
pubmed-meshheading:16644716-Aged,
pubmed-meshheading:16644716-Diabetes Mellitus, Type 2,
pubmed-meshheading:16644716-European Continental Ancestry Group,
pubmed-meshheading:16644716-Female,
pubmed-meshheading:16644716-Genetic Variation,
pubmed-meshheading:16644716-Humans,
pubmed-meshheading:16644716-Insulin Resistance,
pubmed-meshheading:16644716-Interleukin-10,
pubmed-meshheading:16644716-Italy,
pubmed-meshheading:16644716-Linkage Disequilibrium,
pubmed-meshheading:16644716-Male,
pubmed-meshheading:16644716-Middle Aged,
pubmed-meshheading:16644716-Obesity,
pubmed-meshheading:16644716-Polymorphism, Genetic,
pubmed-meshheading:16644716-Polymorphism, Single Nucleotide,
pubmed-meshheading:16644716-Promoter Regions, Genetic
|
pubmed:year |
2006
|
pubmed:articleTitle |
Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects.
|
pubmed:affiliation |
Dipartimento di Medicina Sperimentale e Clinica, Policlinico Mater Domini, University Magna Graecia of Catanzaro, Via Tommaso Campanella, 88100 Catanzaro, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|